Aug 11, 2026 08:25AM
May 13, 2026 07:03AM
Jan 22, 2026 08:45AM
Jan 9, 2026 08:45AM
Dec 9, 2025 08:04AM
Dec 2, 2025 08:32AM
Nov 13, 2025 04:08PM PDS Biotechnology (PDSB) Tops Q3 EPS by 2c
Nov 10, 2025 08:30AM
Oct 29, 2025 08:37AM
Sep 18, 2025 08:45AM
Aug 29, 2025 04:16PM
Aug 13, 2025 07:25AM
Jul 11, 2025 06:38AM
Jul 10, 2025 08:03AM PDS Biotech colorectal cancer trial advances to stage 2 expansion
Jun 11, 2025 06:39AM
Jun 2, 2025 08:03AM
May 22, 2025 05:32PM
May 14, 2025 04:23PM
Mar 28, 2025 06:40AM
Mar 10, 2025 06:51AM
Mar 7, 2025 08:45AM PDS Biotechnology (PDSB) Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer
Feb 27, 2025 08:00AM
Feb 24, 2025 08:00AM
Feb 5, 2025 08:02AM
Nov 14, 2024 08:00AM
Oct 3, 2024 06:59AM
Oct 2, 2024 08:02AM
Sep 16, 2024 07:01AM PDS Biotechnology (PDSB) Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024
Aug 13, 2024 08:10AM
Aug 1, 2024 07:45AM
Jun 12, 2024 08:01AM
Jun 12, 2024 07:37AM

446,469 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All